SQZ Biotechnologies Shares Outstanding 2020-2022 | SQZ

SQZ Biotechnologies shares outstanding from 2020 to 2022. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
SQZ Biotechnologies Annual Shares Outstanding
(Millions of Shares)
2021 28
2020 5
2019 2
SQZ Biotechnologies Quarterly Shares Outstanding
(Millions of Shares)
2022-06-30 28
2022-03-31 28
2021-12-31 28
2021-09-30 28
2021-06-30 28
2021-03-31 26
2020-12-31 5
2020-09-30 2
2020-06-30 2
2020-03-31 2
2019-09-30 2
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.075B $0.027B
SQZ Biotechnologies Company is a clinical-stage biotechnology company. It develops transformative cell therapies for patients with cancer, infectious diseases and other serious conditions. The company's prime product candidate consist SQZ-PBMC-HPV which is in clinical stage. SQZ Biotechnologies Company is based In Watertown, Massachusetts.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $152.564B 9.26
GSK (GSK) United Kingdom $61.844B 7.43
Bio-Rad Laboratories (BIO.B) United States $13.545B 29.93
QIAGEN (QGEN) Netherlands $9.898B 16.57
Ginkgo Bioworks Holdings (DNA) United States $5.908B 0.00
Myovant Sciences (MYOV) United Kingdom $2.391B 0.00
Arcus Biosciences (RCUS) United States $2.007B 39.18
Emergent Biosolutions (EBS) United States $1.039B 6.02
Biohaven Pharmaceutical Holding (BHVN) United States $0.878B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.392B 0.00
Zymeworks (ZYME) Canada $0.354B 0.00
Enzo Biochem (ENZ) United States $0.113B 0.00
Gelesis Holdings (GLS) United States $0.087B 0.00
Ambrx Biopharma (AMAM) United States $0.045B 0.00